| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | HSPD1 MYH3 HSPA4L ZGRF1 MYO18A PSMC1 KIF4A DHX57 KIF3A ABCB11 HELZ ATP6V1C2 SLFN11 DDX60L DDX21 | 1.36e-05 | 614 | 132 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | actin filament binding | 2.05e-05 | 227 | 132 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | phosphatidylserine binding | 1.23e-04 | 73 | 132 | 5 | GO:0001786 | |
| GeneOntologyMolecularFunction | modified amino acid binding | 1.61e-04 | 122 | 132 | 6 | GO:0072341 | |
| GeneOntologyMolecularFunction | actin binding | 3.44e-04 | 479 | 132 | 11 | GO:0003779 | |
| GeneOntologyMolecularFunction | cadherin binding | 4.29e-04 | 339 | 132 | 9 | GO:0045296 | |
| GeneOntologyMolecularFunction | helicase activity | 6.44e-04 | 158 | 132 | 6 | GO:0004386 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | HSPD1 MYH3 MYO18A PSMC1 DHX57 KIF3A ABCB11 SLFN11 DDX60L DDX21 | 7.08e-04 | 441 | 132 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH3 NRAP NEBL MAP2 STXBP5L SYNE1 MYO18A KIF4A NEB KIF3A HOOK3 CTNNA3 CRIPT CTTN ALDOA CDH1 CNN1 | 9.34e-04 | 1099 | 132 | 17 | GO:0008092 |
| GeneOntologyBiologicalProcess | cardiac muscle thin filament assembly | 2.45e-07 | 3 | 130 | 3 | GO:0071691 | |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 2.11e-05 | 239 | 130 | 9 | GO:0031032 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH3 NEBL MAP2 ROR1 SH3GL1 MYO18A NEB ASAP1 PTPN12 CTTN ALDOA CDH1 CNN1 | 7.44e-05 | 576 | 132 | 13 | GO:0015629 |
| GeneOntologyCellularComponent | podosome | 1.28e-04 | 41 | 132 | 4 | GO:0002102 | |
| GeneOntologyCellularComponent | sarcomere | 1.87e-04 | 249 | 132 | 8 | GO:0030017 | |
| GeneOntologyCellularComponent | myofibril | 3.48e-04 | 273 | 132 | 8 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 5.20e-04 | 290 | 132 | 8 | GO:0043292 | |
| Domain | Nebulin | 1.28e-06 | 4 | 129 | 3 | PF00880 | |
| Domain | NEBULIN | 1.28e-06 | 4 | 129 | 3 | PS51216 | |
| Domain | NEBU | 1.28e-06 | 4 | 129 | 3 | SM00227 | |
| Domain | Nebulin | 1.28e-06 | 4 | 129 | 3 | IPR013998 | |
| Domain | Nebulin_repeat | 1.28e-06 | 4 | 129 | 3 | IPR000900 | |
| Domain | THRAP3_BCLAF1 | 1.41e-04 | 3 | 129 | 2 | IPR029199 | |
| Domain | THRAP3_BCLAF1 | 1.41e-04 | 3 | 129 | 2 | PF15440 | |
| Domain | ZnF_C3H1 | 3.34e-04 | 48 | 129 | 4 | SM00356 | |
| Domain | zf-CCCH | 3.62e-04 | 49 | 129 | 4 | PF00642 | |
| Domain | Znf_CCCH | 6.91e-04 | 58 | 129 | 4 | IPR000571 | |
| Domain | ZF_C3H1 | 6.91e-04 | 58 | 129 | 4 | PS50103 | |
| Domain | - | 6.97e-04 | 6 | 129 | 2 | 2.40.50.90 | |
| Domain | Staphylococal_nuclease_OB-fold | 6.97e-04 | 6 | 129 | 2 | IPR016071 | |
| Domain | SH3 | 7.62e-04 | 216 | 129 | 7 | SM00326 | |
| Domain | SH3_domain | 8.49e-04 | 220 | 129 | 7 | IPR001452 | |
| Domain | SH3_1 | 9.78e-04 | 164 | 129 | 6 | PF00018 | |
| Domain | HMG_BOX_1 | 2.05e-03 | 10 | 129 | 2 | PS00353 | |
| Domain | Syntaxin | 2.50e-03 | 11 | 129 | 2 | PF00804 | |
| Domain | - | 2.64e-03 | 40 | 129 | 3 | 4.10.1000.10 | |
| Domain | Syntaxin_N | 2.99e-03 | 12 | 129 | 2 | IPR006011 | |
| Domain | ANX | 3.51e-03 | 13 | 129 | 2 | SM00335 | |
| Domain | Annexin_repeat_CS | 3.51e-03 | 13 | 129 | 2 | IPR018252 | |
| Domain | Annexin | 3.51e-03 | 13 | 129 | 2 | PF00191 | |
| Domain | Annexin_repeat | 3.51e-03 | 13 | 129 | 2 | IPR018502 | |
| Domain | ANNEXIN | 3.51e-03 | 13 | 129 | 2 | PS00223 | |
| Domain | - | 3.51e-03 | 13 | 129 | 2 | 1.10.220.10 | |
| Domain | SH3 | 3.91e-03 | 216 | 129 | 6 | PS50002 | |
| Domain | Annexin | 4.08e-03 | 14 | 129 | 2 | IPR001464 | |
| Domain | TUDOR | 4.08e-03 | 14 | 129 | 2 | PF00567 | |
| Domain | Syntaxin/epimorphin_CS | 5.33e-03 | 16 | 129 | 2 | IPR006012 | |
| Domain | SYNTAXIN | 5.33e-03 | 16 | 129 | 2 | PS00914 | |
| Domain | Myosin_tail_1 | 6.74e-03 | 18 | 129 | 2 | PF01576 | |
| Domain | Myosin_tail | 6.74e-03 | 18 | 129 | 2 | IPR002928 | |
| Pubmed | HSPD1 CACNA2D1 SLC25A6 HSPA4L BCLAF1 ANXA6 UGGT1 SH3GL1 PSMC1 DHX57 FCHO2 SDAD1 STT3A PPM1G ARFGEF3 HOOK3 FANCI EIF2B1 MKI67 EXOC1 CLINT1 DDX60L CTTN ALDOA ENO1 THRAP3 CNOT3 PARP12 | 9.98e-13 | 1440 | 133 | 28 | 30833792 | |
| Pubmed | HSPD1 EPRS1 MYH3 SLC25A6 HSPA4L CWC27 BCLAF1 SYNE1 UGGT1 GPS1 MYO18A DHX57 HMGB2 REL APOB NEB RNF17 STK31 PAEP CAPRIN2 SYCP1 MPHOSPH10 CTTN DDX21 CDH1 ENO1 THRAP3 DOP1A | 1.03e-12 | 1442 | 133 | 28 | 35575683 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HSPD1 EPRS1 SLK HSPA4L BCLAF1 SYNE1 ANXA6 UGGT1 PSMC1 APOB GFPT1 SDAD1 STT3A FANCI EIF2B1 RBM19 CDC16 MKI67 MTR CPSF1 SGO2 CLINT1 CTTN ALDOA DDX21 ENO1 THRAP3 | 4.92e-12 | 1425 | 133 | 27 | 30948266 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | HSPD1 EPRS1 SLC25A6 BCLAF1 UGGT1 MYO18A PSMC1 HMGB2 GFPT1 SDAD1 STT3A PPM1G RBM19 CDC16 MKI67 CPSF1 CLINT1 MPHOSPH10 CTTN ALDOA DDX21 CDH1 ENO1 THRAP3 | 7.64e-11 | 1257 | 133 | 24 | 36526897 |
| Pubmed | EPRS1 CEBPA BCLAF1 ANXA6 UGGT1 DHX57 APOB GFPT1 SDAD1 ITIH3 NRP1 DROSHA EIF2B1 RBM19 CDC16 MKI67 CKAP2L CPSF1 CRIPT CLINT1 ALDOA DDX21 ENO1 THRAP3 PARP12 | 7.66e-11 | 1371 | 133 | 25 | 36244648 | |
| Pubmed | HSPD1 EPRS1 NEBL SLC25A6 HSPA4L BCLAF1 POLD2 SH3GL1 KIF4A HMGB2 GFPT1 KIF3A MKI67 CPSF1 MPHOSPH10 CTTN ALDOA DDX21 CDH1 ENO1 THRAP3 CNOT3 PARP12 | 3.90e-10 | 1247 | 133 | 23 | 27684187 | |
| Pubmed | HSPD1 EPRS1 HECW1 MAP2 STXBP5L BCLAF1 SH3GL1 MYO18A PSMC1 BIRC6 STX1B ASAP1 PPM1G ARFGEF3 CDC16 HELZ EXOC1 CTTN ALDOA ENO1 THRAP3 CNOT3 | 4.19e-10 | 1139 | 133 | 22 | 36417873 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | HSPD1 EPRS1 SLK NEBL BCLAF1 SH3GL1 KIF4A ICE1 GFPT1 PTPN12 ZC3H4 MKI67 HELZ CLINT1 SLFN11 CTTN ALDOA DDX21 ENO1 PARP12 | 4.89e-10 | 934 | 133 | 20 | 33916271 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | HSPD1 EPRS1 BCLAF1 KIF4A HMGB2 ICE1 ZC3H4 FANCI RBM19 WBP4 MKI67 CRIPT SGO2 CLINT1 MPHOSPH10 CTTN ALDOA DDX21 ENO1 THRAP3 | 7.05e-10 | 954 | 133 | 20 | 36373674 |
| Pubmed | HSPD1 EPRS1 BCLAF1 GPS1 KIF4A FCHO2 GFPT1 PTPN12 HOOK3 ZC3H4 FANCI CDC16 MKI67 CTTN THRAP3 | 1.05e-09 | 503 | 133 | 15 | 16964243 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | HSPD1 EPRS1 SLK OXR1 MAP2 HSPA4L POLD2 ANXA6 UGGT1 SH3GL1 GPS1 PSMC1 HMGB2 ELP3 BIRC6 GFPT1 PPM1G TXNRD1 PTPN12 FANCI MTR CLINT1 CTTN ALDOA | 1.42e-09 | 1455 | 133 | 24 | 22863883 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HSPD1 EPRS1 POLD2 PSMC1 KIF4A DHX57 ELP3 BIRC6 MELK GFPT1 ASAP1 PTPN12 FANCI RBM19 MKI67 CPSF1 EXOC1 DDX60L ALDOA DDX21 ENO1 THRAP3 PARP12 | 1.86e-09 | 1353 | 133 | 23 | 29467282 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | SLK CWC27 BCLAF1 SH3GL1 MYO18A DHX57 ZC3H4 RBM19 MKI67 HELZ EXOC1 CLINT1 ZMYM1 MPHOSPH10 CTTN DDX21 THRAP3 | 2.81e-09 | 724 | 133 | 17 | 36232890 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | HSPD1 EPRS1 SLK SLC25A6 HSPA4L BCLAF1 ZGRF1 ANXA6 PSMC1 HMGB2 STT3A PPM1G CTTN ALDOA DDX21 ENO1 THRAP3 DOP1A | 4.39e-09 | 847 | 133 | 18 | 35235311 |
| Pubmed | MYH3 NRAP SYNE1 LAMA2 NEB BIRC6 ZNF181 ASAP1 KIF3A HOOK3 DROSHA EXOC1 ALDOA ENO1 | 8.02e-09 | 497 | 133 | 14 | 23414517 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | SLK BCLAF1 ANXA6 UGGT1 SH3GL1 GPS1 MYO18A PSMC1 GFPT1 STT3A ASAP1 PPM1G TXNRD1 PTPN12 HOOK3 RBM19 EXOC1 CTTN ALDOA DDX21 ENO1 THRAP3 | 1.17e-08 | 1367 | 133 | 22 | 32687490 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | HSPD1 EPRS1 CACNA2D1 SLC25A6 BCLAF1 SYNE1 ANXA6 UGGT1 PSMC1 NRP1 HOOK3 ZC3H4 MKI67 CKAP2L CPSF1 CTTN DDX21 ENO1 THRAP3 | 1.40e-08 | 1024 | 133 | 19 | 24711643 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | NXPE4 CWC27 BCLAF1 ICE1 STK31 ARFGEF3 RBM19 TCEANC2 ALDOA DDX21 ENO1 THRAP3 | 1.62e-08 | 361 | 133 | 12 | 26167880 |
| Pubmed | HSPD1 EPRS1 ANXA6 MYO18A PSMC1 KIF4A FYCO1 BIRC6 MELK STT3A FANCI RBM19 MKI67 HELZ EXOC1 CLINT1 ALDOA DDX21 ENO1 GGA1 | 2.13e-08 | 1168 | 133 | 20 | 19946888 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | HSPD1 EPRS1 SLC25A6 BCLAF1 SYNE1 MYO18A APOB GFPT1 EIF2B1 MKI67 CPSF1 CLINT1 MPHOSPH10 CTTN ALDOA DDX21 ENO1 THRAP3 | 2.50e-08 | 949 | 133 | 18 | 36574265 |
| Pubmed | HSPD1 EPRS1 CACNA2D1 SLK OXR1 MAP2 HSPA4L BCLAF1 SYNE1 SH3GL1 MYO18A PSMC1 DHX57 ELP3 STX1B ASAP1 KIF3A CPNE6 EXOC1 CTTN ALDOA THRAP3 | 2.65e-08 | 1431 | 133 | 22 | 37142655 | |
| Pubmed | SLK SLC25A6 GPS1 DHX57 FYCO1 ELP3 GFPT1 STT3A PPM1G ZC3H4 CDC16 WBP4 CPSF1 CLINT1 ALDOA | 3.41e-08 | 653 | 133 | 15 | 33742100 | |
| Pubmed | HSPD1 CWC27 SYNE1 MYO18A PSMC1 KIF4A APOB RNF17 STT3A PPM1G ADGB SETDB2 CDC16 MKI67 CPSF1 MPHOSPH10 | 3.46e-08 | 754 | 133 | 16 | 35906200 | |
| Pubmed | HSPD1 SLC25A6 CWC27 UGGT1 GPS1 PSMC1 ELP3 SDAD1 FANCI CDC16 WBP4 EXOC1 SLFN11 CNOT3 | 3.55e-08 | 560 | 133 | 14 | 35241646 | |
| Pubmed | UGGT1 RNF17 ELP3 BIRC6 DROSHA MKI67 HELZ EXOC1 ZMYM1 CTTN ALDOA | 7.46e-08 | 335 | 133 | 11 | 15741177 | |
| Pubmed | 8.07e-08 | 142 | 133 | 8 | 30809309 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | HSPD1 EPRS1 SLK SLC25A6 HSPA4L UGGT1 SH3GL1 PSMC1 KIF4A ELP3 BIRC6 GFPT1 PPM1G TXNRD1 ZC3H4 RBM19 CTTN ALDOA DDX21 ENO1 THRAP3 | 1.03e-07 | 1415 | 133 | 21 | 28515276 |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 1.11e-07 | 148 | 133 | 8 | 32538781 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 1.18e-07 | 208 | 133 | 9 | 33230847 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | HSPD1 SLC25A6 CWC27 BCLAF1 SH3GL1 KIF4A SDAD1 PPM1G ZC3H4 FANCI RBM19 MKI67 ATP6V1C2 MPHOSPH10 DDX21 ENO1 THRAP3 | 2.54e-07 | 989 | 133 | 17 | 36424410 |
| Pubmed | 3.43e-07 | 236 | 133 | 9 | 36339263 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | HSPD1 PSMC1 KIF4A RNF17 MELK FANCI CDC16 CPSF1 EXOC1 CLINT1 CTTN DDX21 THRAP3 | 4.04e-07 | 582 | 133 | 13 | 20467437 |
| Pubmed | PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase. | CEBPA SH3GL1 BIRC6 SDAD1 PPM1G CDC16 CLINT1 MPHOSPH10 THRAP3 | 5.03e-07 | 247 | 133 | 9 | 32989298 |
| Pubmed | HSPD1 EPRS1 OXR1 SLC25A6 HSPA4L PSMC1 HMGB2 CDC16 ALDOA DDX21 ENO1 | 5.71e-07 | 411 | 133 | 11 | 36652389 | |
| Pubmed | HSPD1 EPRS1 BCLAF1 UGGT1 MYO18A CTTN ALDOA DDX21 ENO1 THRAP3 | 5.72e-07 | 327 | 133 | 10 | 31409639 | |
| Pubmed | 6.15e-07 | 253 | 133 | 9 | 29911972 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | HSPD1 EPRS1 SLC25A6 BCLAF1 SYNE1 PSMC1 DROSHA WBP4 MKI67 CTTN ALDOA DDX21 ENO1 THRAP3 | 6.73e-07 | 714 | 133 | 14 | 28302793 |
| Pubmed | HSPD1 EPRS1 SLC25A6 HSPA4L POLD2 UGGT1 SH3GL1 GPS1 PSMC1 DHX57 ELP3 SDAD1 PPM1G EIF2B1 CDC16 CTTN ALDOA DDX21 ENO1 | 8.36e-07 | 1335 | 133 | 19 | 29229926 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | HSPA4L BCLAF1 FYCO1 GFPT1 SDAD1 CDC16 MKI67 SGO2 MPHOSPH10 CTTN CDH1 | 1.11e-06 | 440 | 133 | 11 | 34244565 |
| Pubmed | EPRS1 CEBPA BCLAF1 ZNF652 ANXA6 PSMC1 KIF4A HMGB2 PPM1G TXNRD1 FANCI MKI67 CRIPT CLINT1 SLFN11 ALDOA THRAP3 | 1.14e-06 | 1103 | 133 | 17 | 34189442 | |
| Pubmed | 1.19e-06 | 274 | 133 | 9 | 34244482 | ||
| Pubmed | HSPD1 SLC25A6 BCLAF1 PSMC1 APOB FANCI MKI67 CPSF1 SGO2 ALDOA DDX21 ENO1 THRAP3 | 1.43e-06 | 652 | 133 | 13 | 31180492 | |
| Pubmed | ANXA6 UGGT1 KIF4A DHX57 BIRC6 GFPT1 PPM1G FANCI MKI67 CPSF1 HELZ MPHOSPH10 DDX21 | 1.46e-06 | 653 | 133 | 13 | 22586326 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 1.47e-06 | 363 | 133 | 10 | 14691545 | |
| Pubmed | HSPD1 EPRS1 SLC25A6 BCLAF1 GFPT1 ASAP1 PPM1G ZC3H4 MKI67 HELZ CTTN DDX21 THRAP3 | 1.51e-06 | 655 | 133 | 13 | 35819319 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | HSPD1 EPRS1 SLC25A6 HSPA4L POLD2 UGGT1 PSMC1 ELP3 BIRC6 GFPT1 STT3A PPM1G FANCI MTR CPSF1 ALDOA DDX21 ENO1 | 1.53e-06 | 1257 | 133 | 18 | 37317656 |
| Pubmed | HSPD1 BCLAF1 KIF4A APOB BIRC6 PPM1G ARFGEF3 ZC3H4 RBM19 MKI67 CLINT1 ALDOA GGA1 THRAP3 | 1.81e-06 | 777 | 133 | 14 | 35844135 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | OXR1 HSPA4L BCLAF1 UGGT1 DHX57 KIF3A PPM1G CDC16 MKI67 SLFN11 ALDOA ENO1 THRAP3 | 1.93e-06 | 670 | 133 | 13 | 22990118 |
| Pubmed | The dynamic interactome of human Aha1 upon Y223 phosphorylation. | 1.95e-06 | 96 | 133 | 6 | 26693507 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | HSPD1 EPRS1 BCLAF1 ANXA6 DROSHA CLINT1 CTTN ALDOA DDX21 ENO1 THRAP3 | 2.42e-06 | 477 | 133 | 11 | 31300519 |
| Pubmed | FAF1 phosphorylation by AKT accumulates TGF-β type II receptor and drives breast cancer metastasis. | 2.57e-06 | 224 | 133 | 8 | 28443643 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | SLC25A6 CWC27 BCLAF1 PSMC1 HMGB2 REL FYCO1 SDAD1 SAP30 ZC3H4 CPSF1 HELZ MPHOSPH10 CTTN THRAP3 | 2.66e-06 | 922 | 133 | 15 | 27609421 |
| Pubmed | UGGT1 RALGAPB PSMC1 FCHO2 ELP3 BIRC6 SDAD1 ASAP1 PPM1G PTPN12 FANCI MKI67 CPSF1 HELZ CLINT1 SLFN11 | 2.77e-06 | 1049 | 133 | 16 | 27880917 | |
| Pubmed | KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer. | 3.12e-06 | 104 | 133 | 6 | 36055981 | |
| Pubmed | HSPD1 EPRS1 HSPA4L BCLAF1 PSMC1 FCHO2 GFPT1 STT3A PPM1G FANCI CLINT1 CTTN ENO1 | 3.52e-06 | 708 | 133 | 13 | 39231216 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 3.54e-06 | 313 | 133 | 9 | 38270169 | |
| Pubmed | 3.54e-06 | 234 | 133 | 8 | 36243803 | ||
| Pubmed | BCLAF1 MYO18A REL FYCO1 SDAD1 STT3A EIF2B1 MPHOSPH10 ALDOA CDH1 THRAP3 | 4.01e-06 | 503 | 133 | 11 | 36217030 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | HSPD1 MAP2 SLC25A6 BCLAF1 SYNE1 ANXA6 MYO18A DHX57 SDAD1 STT3A ZC3H4 DROSHA CPSF1 CRIPT DDX21 THRAP3 | 4.10e-06 | 1082 | 133 | 16 | 38697112 |
| Pubmed | HSPD1 EPRS1 BCLAF1 KIF4A ZC3H4 MKI67 CKAP2L CPSF1 CTTN DDX21 THRAP3 | 4.25e-06 | 506 | 133 | 11 | 30890647 | |
| Pubmed | Identification of novel CBP interacting proteins in embryonic orofacial tissue. | 4.52e-06 | 9 | 133 | 3 | 15752756 | |
| Pubmed | 5.43e-06 | 330 | 133 | 9 | 32529326 | ||
| Pubmed | 5.76e-06 | 250 | 133 | 8 | 33536335 | ||
| Pubmed | HSPA4L UGGT1 GPS1 MYO18A PPM1G FANCI MKI67 CLINT1 ZMYM1 DDX21 CDH1 ENO1 | 6.28e-06 | 634 | 133 | 12 | 34591612 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | SLC25A6 MYO18A KIF4A DHX57 BIRC6 SDAD1 DROSHA EIF2B1 MKI67 CKAP2L SGO2 MPHOSPH10 DDX21 | 7.44e-06 | 759 | 133 | 13 | 35915203 |
| Pubmed | EPRS1 BCLAF1 SH3GL1 GPS1 PSMC1 HMGB2 PPM1G MKI67 CTTN ALDOA ENO1 | 7.57e-06 | 538 | 133 | 11 | 28524877 | |
| Pubmed | 8.16e-06 | 187 | 133 | 7 | 26460568 | ||
| Pubmed | BCLAF1 POLD2 KIF4A HMGB2 GFPT1 SAP30 PPM1G TXNRD1 FANCI EIF2B1 CDC16 MKI67 CPSF1 CTTN THRAP3 | 8.33e-06 | 1014 | 133 | 15 | 32416067 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 8.50e-06 | 349 | 133 | 9 | 25665578 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | HSPD1 EPRS1 SLK HSPA4L UGGT1 SH3GL1 MYO18A PSMC1 HMGB2 PPM1G ZC3H4 FANCI SLFN11 CTTN ALDOA ENO1 | 8.69e-06 | 1149 | 133 | 16 | 35446349 |
| Pubmed | 8.82e-06 | 11 | 133 | 3 | 21841072 | ||
| Pubmed | HSPD1 SLK HSPA4L MYO18A PSMC1 HMGB2 REL SDAD1 STT3A PPM1G SPZ1 MKI67 MTR CPSF1 HELZ ZMYM1 CTTN CNOT3 | 9.02e-06 | 1429 | 133 | 18 | 35140242 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | EPRS1 BCLAF1 RALGAPB MYO18A SAP30 ZC3H4 MKI67 CPSF1 HELZ CTTN DDX21 THRAP3 CNOT3 | 9.16e-06 | 774 | 133 | 13 | 15302935 |
| Pubmed | SLC25A6 CWC27 BCLAF1 UGGT1 MYO18A KIF4A MKI67 CPSF1 CLINT1 CTTN DDX21 THRAP3 | 9.39e-06 | 660 | 133 | 12 | 32780723 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 9.56e-06 | 268 | 133 | 8 | 33024031 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYH3 SLK HSPA4L BCLAF1 HMGB2 SDAD1 PTPN12 ZC3H4 EIF2B1 CDC16 DDX60L CTTN THRAP3 CNN1 | 1.10e-05 | 910 | 133 | 14 | 36736316 |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 1.19e-05 | 364 | 133 | 9 | 24778252 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | SLC25A6 HSPA4L BCLAF1 DHX57 MELK SDAD1 RBM19 HELZ MPHOSPH10 DDX21 THRAP3 CNOT3 | 1.23e-05 | 678 | 133 | 12 | 30209976 |
| Pubmed | HSPD1 SLC25A6 SYNE1 PSMC1 MKI67 SLFN11 ZMYM1 ALDOA DDX21 ENO1 | 1.25e-05 | 463 | 133 | 10 | 34901782 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | HSPD1 EPRS1 HSPA4L GPS1 PSMC1 BIRC6 STT3A PPM1G FANCI MTR CNOT3 | 1.32e-05 | 571 | 133 | 11 | 37167062 |
| Pubmed | Physiological and pathophysiological characteristics of ataxin-3 isoforms. | 1.35e-05 | 281 | 133 | 8 | 30455355 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | BCLAF1 SYNE1 MYO18A DHX57 HMGB2 ZC3H4 DROSHA RBM19 HELZ MPHOSPH10 ALDOA DDX21 THRAP3 | 1.42e-05 | 807 | 133 | 13 | 22681889 |
| Pubmed | Clathrin adaptor GGA1 modulates myogenesis of C2C12 myoblasts. | 1.45e-05 | 2 | 133 | 2 | 30440034 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 31222140 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 34706761 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 29112714 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 19851499 | ||
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 26631447 | ||
| Pubmed | Loss of E-Cadherin Expression Correlates With Ki-67 in Head and Neck Squamous Cell Carcinoma. | 1.45e-05 | 2 | 133 | 2 | 35478157 | |
| Pubmed | Nuclear localization of aldolase A correlates with cell proliferation. | 1.45e-05 | 2 | 133 | 2 | 23886627 | |
| Pubmed | 1.45e-05 | 2 | 133 | 2 | 22126395 | ||
| Pubmed | Btf and TRAP150 have distinct roles in regulating subcellular mRNA distribution. | 1.45e-05 | 2 | 133 | 2 | 23778535 | |
| Pubmed | Tumor biomarkers in cervical cancer: focus on Ki-67 proliferation factor and E-cadherin expression. | 1.45e-05 | 2 | 133 | 2 | 19690767 | |
| Pubmed | 1.45e-05 | 284 | 133 | 8 | 29459677 | ||
| Pubmed | Intestinal maturation in mice lacking CCAAT/enhancer-binding protein alpha (C/EPBalpha). | 1.52e-05 | 13 | 133 | 3 | 9494081 | |
| Pubmed | Testis development requires the repression of Wnt4 by Fgf signaling. | 1.52e-05 | 13 | 133 | 3 | 22705479 | |
| Pubmed | The proximal signaling network of the BCR-ABL1 oncogene shows a modular organization. | 1.54e-05 | 81 | 133 | 5 | 20697350 | |
| Pubmed | 1.73e-05 | 210 | 133 | 7 | 16565220 | ||
| Pubmed | HSPD1 EPRS1 BCLAF1 MYO18A HMGB2 GFPT1 SDAD1 STT3A DDX60L DDX21 ENO1 THRAP3 | 1.96e-05 | 711 | 133 | 12 | 33022573 | |
| Pubmed | CACNA2D1 SLK HECW1 BCLAF1 SYNE1 WDR81 KIF4A FYCO1 KIF3A HOOK3 ZC3H4 CTTN ENO1 THRAP3 | 2.05e-05 | 963 | 133 | 14 | 28671696 | |
| Interaction | ARL4D interactions | 5.45e-07 | 146 | 133 | 9 | int:ARL4D | |
| Interaction | UHRF2 interactions | CEBPA BCLAF1 KIF4A HMGB2 FANCI CDC16 MKI67 SGO2 DDX21 THRAP3 | 8.66e-07 | 200 | 133 | 10 | int:UHRF2 |
| Interaction | KCNA3 interactions | HSPD1 EPRS1 HSPA4L BCLAF1 MYO18A PSMC1 FYCO1 FCHO2 GFPT1 SDAD1 STT3A PPM1G FANCI CAPRIN2 CTNNA3 CLINT1 CTTN ALDOA ENO1 DOP1A | 1.12e-06 | 871 | 133 | 20 | int:KCNA3 |
| Interaction | PPP5C interactions | USP45 CEBPA MAP2 POLD2 ELP3 BIRC6 ARFGEF3 CDC16 CTTN ALDOA ENO1 | 1.95e-06 | 272 | 133 | 11 | int:PPP5C |
| Interaction | MAP1B interactions | HSPD1 EPRS1 OXR1 SLC25A6 SYNE1 SH3GL1 GPS1 PSMC1 PPM1G MKI67 SLFN11 DDX21 ENO1 THRAP3 CNOT3 | 2.82e-06 | 539 | 133 | 15 | int:MAP1B |
| Interaction | AHSA1 interactions | HSPD1 EPRS1 CEBPA SLC25A6 BCLAF1 GFPT1 PPM1G ALDOA CDH1 ENO1 THRAP3 | 4.12e-06 | 294 | 133 | 11 | int:AHSA1 |
| Interaction | EP300 interactions | SLK CEBPA SLC25A6 POLD2 GPS1 DHX57 HMGB2 REL FYCO1 ELP3 BIRC6 GFPT1 ITIH3 STT3A PPM1G ZC3H4 CDC16 WBP4 CPSF1 CLINT1 CTTN ALDOA CDH1 THRAP3 CNOT3 | 4.47e-06 | 1401 | 133 | 25 | int:EP300 |
| Interaction | LINC01554 interactions | 4.65e-06 | 142 | 133 | 8 | int:LINC01554 | |
| Interaction | BIRC3 interactions | HSPD1 EPRS1 HSPA4L BCLAF1 SYNE1 ANXA6 UGGT1 PSMC1 REL APOB GFPT1 STT3A FANCI EIF2B1 RBM19 MKI67 CPSF1 SGO2 CLINT1 CTTN ALDOA DDX21 ENO1 THRAP3 | 6.24e-06 | 1334 | 133 | 24 | int:BIRC3 |
| Interaction | NAA40 interactions | HSPD1 EPRS1 SLK NEBL BCLAF1 SH3GL1 KIF4A ICE1 GFPT1 PTPN12 ZC3H4 MKI67 HELZ CLINT1 SLFN11 CTTN ALDOA DDX21 ENO1 PARP12 | 6.48e-06 | 978 | 133 | 20 | int:NAA40 |
| Interaction | H3C1 interactions | EPRS1 SLC25A6 POLD2 SYNE1 MYO18A LAMA2 KIF4A HMGB2 NEB SDAD1 MYSM1 PPM1G ZC3H4 CDC16 MKI67 SLFN11 CDH1 THRAP3 JHY | 7.33e-06 | 901 | 133 | 19 | int:H3C1 |
| Interaction | SMC5 interactions | HSPD1 EPRS1 BCLAF1 KIF4A HMGB2 ICE1 ZC3H4 FANCI RBM19 WBP4 MKI67 CRIPT SGO2 CLINT1 MPHOSPH10 CTTN ALDOA DDX21 ENO1 THRAP3 | 8.99e-06 | 1000 | 133 | 20 | int:SMC5 |
| Interaction | MYCN interactions | HSPD1 EPRS1 MAP2 SLC25A6 HSPA4L BCLAF1 SYNE1 UGGT1 PSMC1 DHX57 HMGB2 APOB SDAD1 SAP30 ZC3H4 RBM19 WBP4 MKI67 CPSF1 CRIPT MPHOSPH10 DDX21 ENO1 THRAP3 | 1.01e-05 | 1373 | 133 | 24 | int:MYCN |
| Interaction | TRIB2 interactions | 1.43e-05 | 47 | 133 | 5 | int:TRIB2 | |
| Interaction | TNIP1 interactions | HSPD1 EPRS1 SLC25A6 BCLAF1 SYNE1 MYO18A HMGB2 APOB GFPT1 NRP1 EIF2B1 MKI67 TCEANC2 CPSF1 EXOC1 CLINT1 MPHOSPH10 CTTN ALDOA DDX21 ENO1 THRAP3 | 1.50e-05 | 1217 | 133 | 22 | int:TNIP1 |
| Interaction | C9orf78 interactions | HSPD1 CEBPA SLC25A6 CWC27 UGGT1 GPS1 PSMC1 ELP3 SDAD1 FANCI CDC16 EXOC1 SLFN11 ENO1 CNOT3 | 1.50e-05 | 620 | 133 | 15 | int:C9orf78 |
| Interaction | TRRAP interactions | HSPD1 CEBPA CWC27 SYNE1 MYO18A KIF4A APOB RNF17 ELP3 STT3A PPM1G ADGB SETDB2 MKI67 SLFN11 MPHOSPH10 CNOT3 | 1.79e-05 | 790 | 133 | 17 | int:TRRAP |
| Interaction | IFI16 interactions | HSPD1 CEBPA HSPA4L SYNE1 DHX57 SDAD1 PPM1G EIF2B1 RBM19 PAEP MKI67 HELZ DDX60L MPHOSPH10 DDX21 ENO1 | 1.97e-05 | 714 | 133 | 16 | int:IFI16 |
| Interaction | NEDD9 interactions | 2.10e-05 | 85 | 133 | 6 | int:NEDD9 | |
| Interaction | POLR1E interactions | CEBPA REL ICE1 ELP3 SDAD1 STT3A PPM1G RBM19 SKAP1 SGO2 MPHOSPH10 | 2.12e-05 | 350 | 133 | 11 | int:POLR1E |
| Interaction | HECTD1 interactions | HSPD1 EPRS1 SLC25A6 HSPA4L MYO18A KIF4A DHX57 BIRC6 SDAD1 DROSHA EIF2B1 MKI67 CKAP2L SGO2 EXOC1 ATP6V1C2 MPHOSPH10 DDX21 CDH1 | 2.51e-05 | 984 | 133 | 19 | int:HECTD1 |
| Interaction | CCDC8 interactions | HSPD1 EPRS1 CACNA2D1 SLC25A6 ANXA6 UGGT1 PSMC1 CASQ2 APOB NRP1 HOOK3 MKI67 CKAP2L DDX21 ENO1 | 2.90e-05 | 656 | 133 | 15 | int:CCDC8 |
| Interaction | NPM1 interactions | EPRS1 BCLAF1 DHX57 NEB SDAD1 ZNF181 PPM1G ADGB PTPN12 RBM19 CAPRIN2 SYCP1 MKI67 CPSF1 SLFN11 MINDY4 MPHOSPH10 CTTN DDX21 ENO1 GGA1 | 3.91e-05 | 1201 | 133 | 21 | int:NPM1 |
| Interaction | KCTD13 interactions | HSPD1 EPRS1 CACNA2D1 SLK OXR1 MAP2 HSPA4L BCLAF1 POLD2 SYNE1 SH3GL1 MYO18A PSMC1 DHX57 ELP3 STX1B ASAP1 KIF3A CPNE6 EXOC1 CTTN ALDOA THRAP3 | 3.96e-05 | 1394 | 133 | 23 | int:KCTD13 |
| Interaction | STXBP5L interactions | 4.46e-05 | 11 | 133 | 3 | int:STXBP5L | |
| Interaction | HDLBP interactions | CEBPA UGGT1 DHX57 HMGB2 GFPT1 DROSHA EIF2B1 MKI67 CKAP2L CPSF1 CLINT1 SLFN11 ALDOA CDH1 ENO1 THRAP3 CNOT3 | 4.85e-05 | 855 | 133 | 17 | int:HDLBP |
| Interaction | RIT1 interactions | HSPD1 EPRS1 POLD2 GPS1 PSMC1 ICE1 ELP3 BIRC6 CFAP298 GFPT1 SDAD1 EIF2B1 RBM19 CDC16 WBP4 MTR MPHOSPH10 ALDOA DDX21 ENO1 CNOT3 | 5.52e-05 | 1230 | 133 | 21 | int:RIT1 |
| Interaction | AURKA interactions | HSPD1 EPRS1 CEBPA SH3GL1 REL BIRC6 SDAD1 MYSM1 PPM1G CDC16 CLINT1 ZMYM1 MPHOSPH10 CTTN THRAP3 | 5.68e-05 | 696 | 133 | 15 | int:AURKA |
| Interaction | H1-5 interactions | CEBPA SYNE1 LAMA2 DHX57 CASQ2 CCDC168 MELK ADGB RBM19 SLFN11 MPHOSPH10 DDX21 | 5.84e-05 | 463 | 133 | 12 | int:H1-5 |
| Interaction | FAM9C interactions | 6.00e-05 | 63 | 133 | 5 | int:FAM9C | |
| Interaction | KIF20A interactions | HSPD1 NEBL HSPA4L BCLAF1 SYNE1 MYO18A APOB STX1B FANCI RBM19 MKI67 CPSF1 PIP5K1B HELZ CLINT1 CTTN RNF180 DDX21 THRAP3 | 6.19e-05 | 1052 | 133 | 19 | int:KIF20A |
| Interaction | H2AB2 interactions | 7.73e-05 | 107 | 133 | 6 | int:H2AB2 | |
| Interaction | CHMP4B interactions | HSPD1 EPRS1 CEBPA SLC25A6 BCLAF1 UGGT1 GFPT1 FANCI MKI67 ZMYM1 CTTN DDX21 CDH1 ENO1 THRAP3 | 9.25e-05 | 727 | 133 | 15 | int:CHMP4B |
| Interaction | CCDC65 interactions | 9.70e-05 | 14 | 133 | 3 | int:CCDC65 | |
| Interaction | TULP3 interactions | 1.02e-04 | 346 | 133 | 10 | int:TULP3 | |
| Interaction | NOP56 interactions | CEBPA UGGT1 DHX57 SDAD1 PPM1G EIF2B1 RBM19 MKI67 SLFN11 MPHOSPH10 DDX21 CDH1 ENO1 | 1.04e-04 | 570 | 133 | 13 | int:NOP56 |
| Interaction | YAP1 interactions | HSPD1 EPRS1 SLK HECW1 MAP2 SLC25A6 HSPA4L CWC27 BCLAF1 SH3GL1 KIF4A DROSHA CLINT1 CTTN ALDOA DDX21 CDH1 ENO1 THRAP3 | 1.05e-04 | 1095 | 133 | 19 | int:YAP1 |
| Interaction | KCTD9 interactions | 1.26e-04 | 225 | 133 | 8 | int:KCTD9 | |
| Interaction | MYH9 interactions | HSPD1 USP45 CEBPA GPS1 MYO18A PSMC1 CASQ2 APOB FCHO2 EIF2B1 CLINT1 SLFN11 CTTN CDH1 ENO1 | 1.38e-04 | 754 | 133 | 15 | int:MYH9 |
| Interaction | CDC5L interactions | HSPD1 SLK CWC27 SYNE1 PSMC1 GRB14 KIF4A RNF17 MELK SDAD1 FANCI CDC16 EXOC1 CLINT1 SLFN11 DDX21 | 1.65e-04 | 855 | 133 | 16 | int:CDC5L |
| Interaction | FLNB interactions | 1.91e-04 | 304 | 133 | 9 | int:FLNB | |
| Interaction | NXF1 interactions | HSPD1 EPRS1 CEBPA BCLAF1 MYO18A WDR81 KIF4A HMGB2 SDAD1 DROSHA FANCI RBM19 CDC16 MKI67 MTR CPSF1 HELZ SLFN11 MPHOSPH10 CTTN ALDOA | 1.93e-04 | 1345 | 133 | 21 | int:NXF1 |
| Interaction | VCL interactions | 1.95e-04 | 305 | 133 | 9 | int:VCL | |
| Interaction | RNF113A interactions | HSPD1 EPRS1 CEBPA SLC25A6 BCLAF1 GFPT1 ASAP1 PPM1G ZC3H4 MKI67 HELZ CTTN DDX21 THRAP3 | 1.96e-04 | 692 | 133 | 14 | int:RNF113A |
| Interaction | EFTUD2 interactions | HSPD1 EPRS1 SLK SLC25A6 CWC27 UGGT1 SH3GL1 PSMC1 KIF4A ELP3 BIRC6 GFPT1 SAP30 PPM1G TXNRD1 ZC3H4 RBM19 WBP4 ALDOA DDX21 ENO1 THRAP3 | 1.99e-04 | 1449 | 133 | 22 | int:EFTUD2 |
| Interaction | HSF1 interactions | EPRS1 SLC25A6 HSPA4L BCLAF1 PSMC1 KIF4A RNF17 CDC16 CPSF1 HELZ ALDOA ENO1 THRAP3 | 2.00e-04 | 609 | 133 | 13 | int:HSF1 |
| Interaction | SLFN11 interactions | HSPD1 CEBPA HECW1 DHX57 RBM19 MKI67 CPSF1 HELZ SLFN11 MPHOSPH10 | 2.00e-04 | 376 | 133 | 10 | int:SLFN11 |
| Interaction | H2BC21 interactions | HSPD1 EPRS1 BCLAF1 KIF4A CASQ2 NEB MELK SAP30 PPM1G ZC3H4 CDC16 MKI67 SGO2 DDX60L | 2.08e-04 | 696 | 133 | 14 | int:H2BC21 |
| Interaction | ARL16 interactions | 2.23e-04 | 83 | 133 | 5 | int:ARL16 | |
| Interaction | SMURF1 interactions | HSPD1 USP45 HECW1 BCLAF1 ANXA6 STK31 ELP3 MKI67 PIP5K1B CTTN DDX21 THRAP3 | 2.63e-04 | 544 | 133 | 12 | int:SMURF1 |
| Interaction | GRWD1 interactions | EPRS1 CEBPA HSPA4L BCLAF1 ROR1 PPM1G RBM19 LPIN2 DDX21 THRAP3 | 2.68e-04 | 390 | 133 | 10 | int:GRWD1 |
| Interaction | SIRT6 interactions | HSPA4L BCLAF1 POLD2 KIF4A FYCO1 GFPT1 SDAD1 CDC16 MKI67 SGO2 MPHOSPH10 CTTN CDH1 | 2.69e-04 | 628 | 133 | 13 | int:SIRT6 |
| Interaction | GLDC interactions | 2.85e-04 | 321 | 133 | 9 | int:GLDC | |
| Interaction | FGFR1 interactions | HSPD1 SLC25A6 HSPA4L ROR1 SH3GL1 GRB14 FCHO2 ASAP1 NRP1 FANCI CLINT1 CDH1 GGA1 | 2.86e-04 | 632 | 133 | 13 | int:FGFR1 |
| Interaction | SPAST interactions | 2.88e-04 | 136 | 133 | 6 | int:SPAST | |
| Interaction | SF3A1 interactions | HSPD1 CEBPA CWC27 BCLAF1 SYNE1 PSMC1 PTPN12 WBP4 SLFN11 ENO1 THRAP3 | 2.95e-04 | 471 | 133 | 11 | int:SF3A1 |
| Interaction | OBSL1 interactions | HSPD1 MAP2 BCLAF1 SYNE1 DHX57 CASQ2 SDAD1 ZC3H4 RBM19 MKI67 CPSF1 CTTN ALDOA DDX21 ENO1 THRAP3 | 3.02e-04 | 902 | 133 | 16 | int:OBSL1 |
| Interaction | BRSK2 interactions | 3.43e-04 | 91 | 133 | 5 | int:BRSK2 | |
| Interaction | DDX23 interactions | SLK CEBPA CWC27 BCLAF1 SYNE1 SDAD1 RBM19 WBP4 MPHOSPH10 DDX21 THRAP3 | 3.46e-04 | 480 | 133 | 11 | int:DDX23 |
| Interaction | PREP interactions | 3.61e-04 | 92 | 133 | 5 | int:PREP | |
| Interaction | FLNA interactions | EPRS1 USP45 CEBPA ZGRF1 MYO18A HMGB2 REL PTPN12 CAPRIN2 CLINT1 SLFN11 CTTN CDH1 | 3.63e-04 | 648 | 133 | 13 | int:FLNA |
| Interaction | PSG9 interactions | 3.95e-04 | 22 | 133 | 3 | int:PSG9 | |
| Interaction | LOXL2 interactions | HSPD1 EPRS1 BCLAF1 UGGT1 MYO18A CTTN ALDOA DDX21 ENO1 THRAP3 | 3.98e-04 | 410 | 133 | 10 | int:LOXL2 |
| Interaction | DDX39B interactions | HSPD1 BCLAF1 MYO18A HMGB2 GFPT1 PTPN12 SLFN11 ALDOA DDX21 CDH1 ENO1 THRAP3 | 4.01e-04 | 570 | 133 | 12 | int:DDX39B |
| Interaction | POLR1G interactions | CWC27 HMGB2 REL ICE1 SDAD1 PPM1G RBM19 SKAP1 SGO2 MPHOSPH10 DDX21 | 4.05e-04 | 489 | 133 | 11 | int:POLR1G |
| Interaction | H1-4 interactions | EPRS1 DHX57 NEB SDAD1 ASAP1 TXNRD1 PTPN12 RBM19 TCEANC2 SLFN11 MPHOSPH10 DDX21 CDH1 | 4.08e-04 | 656 | 133 | 13 | int:H1-4 |
| Interaction | HDAC4 interactions | HSPD1 EPRS1 CACNA2D1 CEBPA HSPA4L DHX57 HMGB2 FCHO2 MELK KIF3A PPM1G DDX21 ENO1 THRAP3 | 4.09e-04 | 744 | 133 | 14 | int:HDAC4 |
| Interaction | ISG15 interactions | HSPD1 EPRS1 SLC25A6 BCLAF1 MYO18A PSMC1 TXNRD1 CLINT1 ALDOA ENO1 THRAP3 | 4.41e-04 | 494 | 133 | 11 | int:ISG15 |
| Interaction | KIF23 interactions | HSPD1 EPRS1 SLC25A6 BCLAF1 PSMC1 LAMA2 DHX57 FYCO1 BIRC6 GFPT1 DROSHA MKI67 CPSF1 MPHOSPH10 DDX21 ENO1 THRAP3 | 4.50e-04 | 1031 | 133 | 17 | int:KIF23 |
| Interaction | LYPLA2 interactions | 4.76e-04 | 55 | 133 | 4 | int:LYPLA2 | |
| Interaction | PPIB interactions | 4.82e-04 | 345 | 133 | 9 | int:PPIB | |
| Interaction | ASAP1 interactions | 4.82e-04 | 98 | 133 | 5 | int:ASAP1 | |
| Interaction | TET2 interactions | 4.85e-04 | 150 | 133 | 6 | int:TET2 | |
| Interaction | CHD3 interactions | HSPD1 EPRS1 CEBPA SLC25A6 BCLAF1 SDAD1 SAP30 MKI67 CPSF1 SLFN11 CTTN DDX21 ENO1 THRAP3 | 4.86e-04 | 757 | 133 | 14 | int:CHD3 |
| Cytoband | 10p12 | 1.73e-04 | 7 | 133 | 2 | 10p12 | |
| Cytoband | 6q22-q23 | 3.69e-04 | 10 | 133 | 2 | 6q22-q23 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | EPRS1 SLK HSPA4L CWC27 BCLAF1 SDAD1 KIF3A WBP4 CAPRIN2 MKI67 MTR EXOC1 ZMYM1 MPHOSPH10 DDX21 CDH1 | 2.35e-07 | 656 | 133 | 16 | M18979 |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP | 3.01e-07 | 176 | 133 | 9 | M2981 | |
| Coexpression | FISCHER_DREAM_TARGETS | HSPD1 CWC27 BCLAF1 POLD2 ZGRF1 KIF4A HMGB2 BIRC6 MELK SAP30 FANCI MKI67 CKAP2L SGO2 SLFN11 ZMYM1 DDX21 THRAP3 | 2.06e-06 | 969 | 133 | 18 | M149 |
| Coexpression | SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP | 3.24e-06 | 45 | 133 | 5 | M104 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP | 3.99e-06 | 180 | 133 | 8 | M8127 | |
| Coexpression | GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_DN | 8.35e-06 | 199 | 133 | 8 | M8487 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | HSPD1 EPRS1 OXR1 BCLAF1 ROR1 RALGAPB MELK GFPT1 ASAP1 TXNRD1 PTPN12 SGO2 MPHOSPH10 ENO1 | 1.88e-05 | 721 | 133 | 14 | M10237 |
| Coexpression | GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_FOXP3_TRASDUCED_CD4_TCELL_DN | 1.96e-05 | 162 | 133 | 7 | M8995 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | HSPD1 EPRS1 HSPA4L POLD2 ROR1 HMGB2 GFPT1 PTPN12 FANCI MKI67 SGO2 MPHOSPH10 ENO1 | 2.54e-05 | 644 | 133 | 13 | M10501 |
| Coexpression | VILLANUEVA_LIVER_CANCER_KRT19_UP | 3.22e-05 | 175 | 133 | 7 | M336 | |
| Coexpression | GSE14415_INDUCED_VS_NATURAL_TREG_DN | 3.99e-05 | 181 | 133 | 7 | M2969 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | POLD2 ZGRF1 KIF4A MELK TXNRD1 FANCI MKI67 CKAP2L SGO2 SLFN11 | 4.07e-05 | 402 | 133 | 10 | MM454 |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP | 4.25e-05 | 404 | 133 | 10 | M19488 | |
| Coexpression | LAKE_ADULT_KIDNEY_C19_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_MEDULLA | 4.50e-05 | 326 | 133 | 9 | M39238 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_EARLY_SUPRABASAL_CELLS | 5.20e-05 | 79 | 133 | 5 | M40003 | |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN | 5.43e-05 | 190 | 133 | 7 | M761 | |
| Coexpression | IBRAHIM_NRF1_UP | HSPD1 GFPT1 EIF2B1 RBM19 CLINT1 ATP6V1C2 MPHOSPH10 CTTN ALDOA DDX21 | 5.87e-05 | 420 | 133 | 10 | M42509 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SLK TOX BCLAF1 SYNE1 ZNF652 ANXA6 RALGAPB ICE1 BIRC6 MYSM1 ASAP1 CDC16 SKAP1 LPIN2 MTR HELZ SLFN11 TRAF3IP3 ENO1 THRAP3 | 6.46e-05 | 1492 | 133 | 20 | M40023 |
| Coexpression | GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP | 6.82e-05 | 197 | 133 | 7 | M3136 | |
| Coexpression | GSE12366_GC_VS_MEMORY_BCELL_UP | 7.04e-05 | 198 | 133 | 7 | M3171 | |
| Coexpression | GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_DN | 7.26e-05 | 199 | 133 | 7 | M8314 | |
| Coexpression | GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_UP | 7.49e-05 | 200 | 133 | 7 | M9437 | |
| Coexpression | GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_DN | 7.49e-05 | 200 | 133 | 7 | M4587 | |
| Coexpression | GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_DN | 7.49e-05 | 200 | 133 | 7 | M3597 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | HSPD1 EPRS1 CACNA2D1 SLK NEBL MAP2 HSPA4L ZNF652 ROR1 GFPT1 ASAP1 KIF3A TXNRD1 ENO1 ST18 | 9.46e-05 | 946 | 133 | 15 | M39169 |
| Coexpression | BUSSLINGER_GASTRIC_ISTHMUS_CELLS | 1.20e-04 | 458 | 133 | 10 | M40010 | |
| Coexpression | LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX | 1.29e-04 | 152 | 133 | 6 | M39239 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_1_DN | 1.39e-04 | 378 | 133 | 9 | M17788 | |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 1.43e-04 | 155 | 133 | 6 | M39041 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_2_CELL | 1.53e-04 | 300 | 133 | 8 | M45675 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGBP | 1.53e-04 | 300 | 133 | 8 | M39059 | |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP | 1.56e-04 | 384 | 133 | 9 | M798 | |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN | HSPD1 EPRS1 POLD2 KIF4A ELP3 MELK STT3A PPM1G FANCI MKI67 ALDOA ENO1 | 1.60e-04 | 669 | 133 | 12 | M18635 |
| Coexpression | KANG_DOXORUBICIN_RESISTANCE_UP | 1.65e-04 | 54 | 133 | 4 | M1037 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNPROG | 1.74e-04 | 229 | 133 | 7 | M39062 | |
| Coexpression | TRAVAGLINI_LUNG_PROLIFERATING_BASAL_CELL | HSPD1 EPRS1 SLC25A6 POLD2 KIF4A HMGB2 MELK PPM1G FANCI MKI67 CKAP2L SGO2 ALDOA ENO1 | 1.80e-04 | 891 | 133 | 14 | M41654 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | OXR1 MYO18A HMGB2 SAP30 ASAP1 CDC16 CAPRIN2 MTR CPSF1 CLINT1 CTTN CDH1 PARP12 | 1.98e-04 | 790 | 133 | 13 | M12490 |
| Coexpression | FISCHER_G2_M_CELL_CYCLE | 2.09e-04 | 236 | 133 | 7 | M130 | |
| Coexpression | WHITFIELD_CELL_CYCLE_G2 | 2.22e-04 | 168 | 133 | 6 | M2076 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | MAP2 POLD2 KIF4A HMGB2 MELK FANCI LPIN2 MKI67 CKAP2L SGO2 SLFN11 | 2.40e-04 | 597 | 133 | 11 | MM1309 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL | 2.47e-04 | 322 | 133 | 8 | M39060 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | HSPD1 EPRS1 CACNA2D1 ZGRF1 KIF4A HMGB2 ELP3 MELK ASAP1 FANCI EIF2B1 MKI67 MTR SGO2 DDX60L DDX21 ENO1 PARP12 | 2.75e-04 | 1407 | 133 | 18 | M14427 |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | HSPD1 USP45 ROR1 KIF4A HMGB2 MELK GFPT1 ASAP1 FANCI EIF2B1 SYCP1 MKI67 CKAP2L SGO2 SLFN11 DDX21 ENO1 | 2.92e-04 | 1290 | 133 | 17 | M80 |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 2.96e-04 | 250 | 133 | 7 | M11318 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR | 3.12e-04 | 516 | 133 | 10 | M11166 | |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP | 3.12e-04 | 179 | 133 | 6 | M3268 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | 3.36e-04 | 426 | 133 | 9 | M9516 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL | 4.50e-04 | 268 | 133 | 7 | M45696 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPM | 4.64e-04 | 354 | 133 | 8 | M39061 | |
| Coexpression | BENPORATH_CYCLING_GENES | BCLAF1 HMGB2 ELP3 MELK SAP30 TXNRD1 FANCI CDC16 MKI67 ZMYM1 THRAP3 | 4.80e-04 | 648 | 133 | 11 | M8156 |
| Coexpression | IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR | 4.99e-04 | 548 | 133 | 10 | MM1013 | |
| Coexpression | GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_UP | 5.06e-04 | 196 | 133 | 6 | M3239 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_PRO_BCELL_DN | 5.06e-04 | 196 | 133 | 6 | M8856 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_COMMON_LYMPHOID_PROGENITOR_UP | 5.06e-04 | 196 | 133 | 6 | M8875 | |
| Coexpression | GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_UP | 5.06e-04 | 196 | 133 | 6 | M5252 | |
| Coexpression | GSE360_L_DONOVANI_VS_T_GONDII_DC_DN | 5.19e-04 | 197 | 133 | 6 | M5196 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_UP | 5.33e-04 | 198 | 133 | 6 | M4639 | |
| Coexpression | GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN | 5.33e-04 | 198 | 133 | 6 | M6511 | |
| Coexpression | GSE3982_BCELL_VS_TH1_DN | 5.33e-04 | 198 | 133 | 6 | M5553 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_DN | SLK OXR1 CWC27 ZNF652 MELK MYSM1 STT3A HOOK3 ZC3H4 FANCI SGO2 CTTN DOP1A | 5.35e-04 | 877 | 133 | 13 | M2241 |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_DN | 5.48e-04 | 199 | 133 | 6 | M8029 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN | 5.48e-04 | 199 | 133 | 6 | M3440 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_UP | 5.48e-04 | 199 | 133 | 6 | M8961 | |
| Coexpression | GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_UP | 5.62e-04 | 200 | 133 | 6 | M9474 | |
| Coexpression | GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_UP | 5.62e-04 | 200 | 133 | 6 | M8085 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_DN | 5.62e-04 | 200 | 133 | 6 | M4529 | |
| Coexpression | GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_UP | 5.62e-04 | 200 | 133 | 6 | M315 | |
| Coexpression | GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_UP | 5.62e-04 | 200 | 133 | 6 | M3236 | |
| Coexpression | GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_UP | 5.62e-04 | 200 | 133 | 6 | M8308 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP | 5.62e-04 | 200 | 133 | 6 | M3580 | |
| Coexpression | GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_UP | 5.62e-04 | 200 | 133 | 6 | M9536 | |
| Coexpression | GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN | 5.62e-04 | 200 | 133 | 6 | M7143 | |
| Coexpression | GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_DN | 5.62e-04 | 200 | 133 | 6 | M3678 | |
| Coexpression | GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP | 5.62e-04 | 200 | 133 | 6 | M5041 | |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP | 5.62e-04 | 200 | 133 | 6 | M6661 | |
| Coexpression | GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN | 5.62e-04 | 200 | 133 | 6 | M7915 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_DN | 5.62e-04 | 200 | 133 | 6 | M7958 | |
| Coexpression | GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_DN | 5.62e-04 | 200 | 133 | 6 | M5225 | |
| Coexpression | GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN | 5.62e-04 | 200 | 133 | 6 | M7891 | |
| Coexpression | GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_DN | 5.62e-04 | 200 | 133 | 6 | M5592 | |
| Coexpression | GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_DN | 5.62e-04 | 200 | 133 | 6 | M9084 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_UP | 5.62e-04 | 200 | 133 | 6 | M4488 | |
| Coexpression | KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_UP | 5.62e-04 | 200 | 133 | 6 | M3023 | |
| Coexpression | ZHONG_PFC_C2_UNKNOWN_NPC | 6.13e-04 | 76 | 133 | 4 | M39087 | |
| Coexpression | GREENBAUM_E2A_TARGETS_UP | 6.23e-04 | 33 | 133 | 3 | M1490 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500 | HSPA4L RNF17 STK31 MELK SETDB2 OLIG3 FANCI CAPRIN2 SYCP1 MTR HELZ SGO2 ZMYM1 CDH1 PARP12 | 3.63e-08 | 406 | 132 | 15 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | HSPA4L ZGRF1 KIF4A RNF17 STK31 MELK SDAD1 SETDB2 OLIG3 DROSHA FANCI CAPRIN2 SYCP1 MTR HELZ SGO2 ZMYM1 DDX21 CDH1 PARP12 | 1.77e-07 | 822 | 132 | 20 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | HSPA4L ZGRF1 KIF4A REL RNF17 STK31 MELK STX1B SETDB2 OLIG3 FANCI CAPRIN2 SYCP1 MTR HELZ SGO2 CDH1 DOP1A PARP12 | 7.76e-07 | 820 | 132 | 19 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | HSPA4L ZGRF1 RNF17 STK31 MELK SDAD1 SETDB2 DROSHA FANCI CAPRIN2 SYCP1 MTR SGO2 ZMYM1 MPHOSPH10 DDX21 CDH1 PARP12 | 2.16e-06 | 795 | 132 | 18 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3 | HSPD1 TOX NEBL POLD2 KIF4A HMGB2 MELK FANCI SKAP1 MKI67 CKAP2L SGO2 CDH1 | 2.20e-06 | 419 | 132 | 13 | GSM476664_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | HSPA4L ZGRF1 REL RNF17 STK31 MELK SETDB2 OLIG3 FANCI CAPRIN2 SYCP1 PARP12 | 5.26e-06 | 385 | 132 | 12 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_500 | HSPA4L RNF17 STK31 MELK FANCI CAPRIN2 SYCP1 MTR SGO2 DDX21 CDH1 PARP12 | 5.54e-06 | 387 | 132 | 12 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_500 |
| CoexpressionAtlas | alpha beta T cells, NKT.44+NK1.1-.Th, aGC CD1d tet CD3 CD44, Thymus, avg-3 | HSPD1 TOX MAP2 KIF4A HMGB2 MELK NRP1 SKAP1 MKI67 CKAP2L PIP5K1B SGO2 | 6.31e-06 | 392 | 132 | 12 | GSM538335_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_500 | HSPA4L RNF17 STK31 DROSHA CAPRIN2 SYCP1 MTR SGO2 ZMYM1 DDX21 CDH1 PARP12 | 6.99e-06 | 396 | 132 | 12 | gudmap_dev gonad_e13.5_M_GermCell_Oct_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000 | ZGRF1 RNF17 STK31 MELK SDAD1 PPM1G OLIG3 FANCI CAPRIN2 MTR HELZ SGO2 ZMYM1 DDX21 CDH1 THRAP3 PARP12 | 9.61e-06 | 799 | 132 | 17 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | TOX ZGRF1 ANXA6 KIF4A HMGB2 MELK NRP1 FANCI SKAP1 MKI67 CKAP2L SGO2 | 9.92e-06 | 410 | 132 | 12 | GSM538387_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | HSPA4L CWC27 RNF17 STK31 MELK SDAD1 SETDB2 DROSHA CAPRIN2 SYCP1 MTR SGO2 ZMYM1 MPHOSPH10 DDX21 CDH1 PARP12 | 1.15e-05 | 810 | 132 | 17 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | HSPD1 NEBL ZGRF1 KIF4A HMGB2 MELK NRP1 FANCI SKAP1 MKI67 CKAP2L SGO2 | 1.17e-05 | 417 | 132 | 12 | GSM399403_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 2.55e-05 | 56 | 132 | 5 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_200 | 3.17e-05 | 143 | 132 | 7 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_200 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3 | HSPD1 POLD2 ZGRF1 KIF4A HMGB2 MELK NRP1 SKAP1 MKI67 CKAP2L SGO2 | 3.89e-05 | 397 | 132 | 11 | GSM791143_500 |
| CoexpressionAtlas | alpha beta T cells, NKT.44-NK1.1-.Th, aGC CD1d tet CD3e, Thymus, avg-2 | TOX MAP2 HSPA4L KIF4A HMGB2 MELK NRP1 SKAP1 MKI67 CKAP2L SGO2 | 3.98e-05 | 398 | 132 | 11 | GSM538338_500 |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | NEBL ZGRF1 KIF4A HMGB2 MELK NRP1 FANCI SKAP1 MKI67 CKAP2L SGO2 | 3.98e-05 | 398 | 132 | 11 | GSM399397_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.75e-05 | 104 | 132 | 6 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 6.55e-05 | 68 | 132 | 5 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.06e-05 | 71 | 132 | 5 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.62e-05 | 72 | 132 | 5 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k4_1000 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.25e-05 | 293 | 132 | 9 | gudmap_kidney_P0_JuxtaGlom_Ren1_k3_1000 | |
| CoexpressionAtlas | alpha beta T cells, T.DP.Th, 4+ 8+ TCR-/lo 69-, Thymus, avg-3 | 1.01e-04 | 367 | 132 | 10 | GSM399391_500 | |
| CoexpressionAtlas | alpha beta T cells, T.DN4.Th, Lin-/lo CD25- CD44- CD28+, Thymus, avg-3 | 1.24e-04 | 376 | 132 | 10 | GSM791154_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 2.12e-04 | 402 | 132 | 10 | GSM605898_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_200 | 2.35e-04 | 139 | 132 | 6 | gudmap_dev gonad_e13.5_M_GermCell_Oct_200 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | 2.48e-04 | 90 | 132 | 5 | GSM399397_100 | |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1 | 3.13e-04 | 422 | 132 | 10 | GSM538357_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_200 | 3.18e-04 | 147 | 132 | 6 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_200 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | HSPD1 EPRS1 NEBL BCLAF1 HMGB2 MELK CFAP298 SDAD1 SAP30 RBM19 SKAP1 CKAP2L SGO2 ZMYM1 MPHOSPH10 ALDOA DDX21 ENO1 | 3.19e-04 | 1164 | 132 | 18 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | HSPA4L BCLAF1 ANXA6 REL RNF17 STK31 BIRC6 MYSM1 KIF3A SETDB2 PTPN12 SYCP1 MTR PARP12 | 3.43e-04 | 776 | 132 | 14 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.47e-04 | 210 | 132 | 7 | gudmap_developingGonad_e14.5_ ovary_1000_k1 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000 | RNF17 STK31 MELK SDAD1 FANCI CAPRIN2 MTR HELZ SGO2 ZMYM1 MPHOSPH10 DDX21 CDH1 PARP12 | 3.66e-04 | 781 | 132 | 14 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | alpha beta T cells, T.8.TI.B16, 4- 8+ TCR+ 45+, B16 Melanoma Tumor, avg-2 | 4.18e-04 | 359 | 132 | 9 | GSM605773_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 5.69e-04 | 164 | 132 | 6 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.25e-04 | 110 | 132 | 5 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | HSPD1 EPRS1 NEBL HSPA4L BCLAF1 HMGB2 MELK CFAP298 SDAD1 SAP30 RBM19 SKAP1 CKAP2L SGO2 ZMYM1 MPHOSPH10 ALDOA DDX21 ENO1 | 6.69e-04 | 1347 | 132 | 19 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_500 | 7.03e-04 | 386 | 132 | 9 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | MYH3 USP45 TOX HECW1 NEBL OXR1 MAP2 ICE1 NEB GFPT1 PTPN12 HOOK3 SGO2 RNF180 | 7.16e-04 | 836 | 132 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 7.42e-04 | 311 | 132 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.64e-04 | 115 | 132 | 5 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.27e-04 | 243 | 132 | 7 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.54e-04 | 68 | 132 | 4 | gudmap_developingGonad_e16.5_testes_1000_k1 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_500 | 9.02e-04 | 69 | 132 | 4 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_500 | |
| CoexpressionAtlas | B cells, proB.FrBC.FL, CD19+ IgM- CD43+ CD24+ AA4.1+ CD45R+, Fetal Liver, avg-3 | 9.04e-04 | 400 | 132 | 9 | GSM538358_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_500 | 9.09e-04 | 247 | 132 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k4 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.84e-09 | 174 | 133 | 9 | 41eb0a214a8b4015a26311f77061c8147144f0e7 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.13e-09 | 176 | 133 | 9 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.85e-09 | 189 | 133 | 9 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.41e-09 | 191 | 133 | 9 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.02e-09 | 193 | 133 | 9 | b835d28de9daeec5213172c96f62b332cda53bb5 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.68e-09 | 195 | 133 | 9 | 67670d16ddd5d5ab7bc2254df329f5a7b2581556 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.68e-09 | 195 | 133 | 9 | 23dc2f8a3a038195a31feee7e3a51094a7a7c23e | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 7.68e-09 | 195 | 133 | 9 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 8.03e-09 | 196 | 133 | 9 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | Severe-Developping_Plasmablast|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.57e-09 | 200 | 133 | 9 | 6d0cd00e52568d23597cc2a4059bd967d7d2dab5 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.49e-08 | 164 | 133 | 8 | ae09e5aabd1347b865474255e7411c04f63efb3b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.41e-08 | 169 | 133 | 8 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.83e-08 | 171 | 133 | 8 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.83e-08 | 171 | 133 | 8 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-08 | 174 | 133 | 8 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-08 | 175 | 133 | 8 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.31e-08 | 177 | 133 | 8 | a68c3688f12aee22f3cb4049c4bccacbacb0fae6 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.19e-08 | 180 | 133 | 8 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.82e-08 | 182 | 133 | 8 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 7.82e-08 | 182 | 133 | 8 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 8.51e-08 | 184 | 133 | 8 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.51e-08 | 184 | 133 | 8 | d1e0e3b0eed2db8a5b7e3d6f81294667e4ba64e5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.88e-08 | 185 | 133 | 8 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.64e-08 | 187 | 133 | 8 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.64e-08 | 187 | 133 | 8 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.05e-07 | 189 | 133 | 8 | d6bd46abb072b13a6b72f1ca25d19f218cceb1ff | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.09e-07 | 190 | 133 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-07 | 190 | 133 | 8 | b3bccf4dd95e986db3cee324a6737f5fcc22e8e5 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T|GI_small-bowel / Manually curated celltypes from each tissue | 1.13e-07 | 191 | 133 | 8 | e642fa7395c05fb53324c9d46bbc52f89fc9673f | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 1.33e-07 | 195 | 133 | 8 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.33e-07 | 195 | 133 | 8 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.33e-07 | 195 | 133 | 8 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.38e-07 | 196 | 133 | 8 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.38e-07 | 196 | 133 | 8 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.38e-07 | 196 | 133 | 8 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 1.49e-07 | 198 | 133 | 8 | b2868a897dd96494cf1829c30e0ce508f52efdf3 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.49e-07 | 198 | 133 | 8 | 880f9817f5145f10f29fc05c5866090433532fe2 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.49e-07 | 198 | 133 | 8 | bcfe7b6d91f2e2f145cb2660b65fd2a6c1134b86 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.49e-07 | 198 | 133 | 8 | 36897e17de2e22ee6b23920ee6e60931903f3e5c | |
| ToppCell | (0)_NK_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.49e-07 | 198 | 133 | 8 | 5ebb4965b723302152b42bfaf48bb77a57dd02c5 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.55e-07 | 199 | 133 | 8 | 3d876f172487425b37b2f658dae59e0f293ee76e | |
| ToppCell | Mild/Remission-Developping_Plasmablast|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.55e-07 | 199 | 133 | 8 | 58c772ec763109a4009f52424fbb214fc23d0c09 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Proliferating_Epithelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.55e-07 | 199 | 133 | 8 | d73667e2e93026d95184e24ff0bc90afd1fb74a9 | |
| ToppCell | Severe-Lymphoid-T-Proliferating_T|Severe / Condition, Lineage, Cell class and cell subclass | 1.61e-07 | 200 | 133 | 8 | 266270c756fb69945449ce02da04743cd31f8158 | |
| ToppCell | (5)_Epi_dividing|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.61e-07 | 200 | 133 | 8 | 948c55aa1c25f8a69b1bd3ef53fd32aa222f592c | |
| ToppCell | (5)_Epithelial_cells-(5)_Epi_dividing|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.61e-07 | 200 | 133 | 8 | b46b2064362efc64edf19ab2b21bc89047c9d943 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.61e-07 | 200 | 133 | 8 | 3c3ac587ad98e3f6be809eac18c7742a23140de1 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.61e-07 | 200 | 133 | 8 | 5c84aaedac9f27da0da0493dab7c8f7a4d66888c | |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK-Cycling_NK|Lung / Manually curated celltypes from each tissue | 1.61e-07 | 200 | 133 | 8 | 381bafdde6492f020ae93ab8fffa6215c631c570 | |
| ToppCell | ILEUM-inflamed-(1)_Highly_activated_T_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.61e-07 | 200 | 133 | 8 | 6ff811fdfe49b5b0aea0e88fae80bfaaf40eb7c4 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.61e-07 | 200 | 133 | 8 | 43571c9284d4e41402a2d1eefc1efe2ce8476d4a | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.61e-07 | 200 | 133 | 8 | dd7ad295ab3ba4c19babffb1625900db414bb5a9 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.61e-07 | 200 | 133 | 8 | cab374b7c56310329951c2ca44a7179ffa895b7d | |
| ToppCell | Severe-Developping_Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.61e-07 | 200 | 133 | 8 | 80639e0d2ddaae36ac7634a4f03e8809af7316e3 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.11e-07 | 163 | 133 | 7 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.36e-07 | 164 | 133 | 7 | 249d8f75a64bce7db52ce0c563f496b9edf602a6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.63e-07 | 165 | 133 | 7 | eec2d327c94832d1390314c93ef6a2be4648478b | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.63e-07 | 165 | 133 | 7 | 26c750f10f6401752e2e63d91dc844c81b29d735 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.90e-07 | 166 | 133 | 7 | 6fe8db8d45177a78605681f22e04fa8d0594f2df | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.19e-07 | 167 | 133 | 7 | d21635df8b74189e3309eaf435af381fbe412574 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.48e-07 | 168 | 133 | 7 | b7cd33f5da4f37b9384fc3bd3ca01fbc790accfc | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.10e-07 | 170 | 133 | 7 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.10e-07 | 170 | 133 | 7 | a0d6466e00bd3dc07f644ba3f87d5b421fd479d5 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T|Lung / Manually curated celltypes from each tissue | 8.43e-07 | 171 | 133 | 7 | 976361f67dd725870e0513ae7a92f2dcaee17148 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue | 9.11e-07 | 173 | 133 | 7 | 8a9dd85f718564c07cf3120ad648daeb60c94fc5 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.47e-07 | 174 | 133 | 7 | c988471207ba06195bc3e41056435e8c31c20bbe | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.47e-07 | 174 | 133 | 7 | c26eac176e9b0cba385630fdc60e0314a4e4caac | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Promonocyte-like|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 9.84e-07 | 175 | 133 | 7 | 654299df246debe0a5b12f0d9568eb828bb94bb9 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.84e-07 | 175 | 133 | 7 | d43ae33a6256606ce848247cad32d74f21b38988 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-06 | 177 | 133 | 7 | 3081ce5fc66a1bb833719d6c0e0a6fc7115eeb91 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-06 | 177 | 133 | 7 | ba701d3c90722d8bff70d0fa651899305cdad257 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-06 | 180 | 133 | 7 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-06 | 181 | 133 | 7 | 73b1b59810f60e3e39ca1d5073a5a0d4f5377e6e | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.23e-06 | 181 | 133 | 7 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | Healthy_Control-Lymphoid-T-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.23e-06 | 181 | 133 | 7 | ac1ee313910c05b1b3cb497bae14565464919c21 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 1.33e-06 | 183 | 133 | 7 | a48a6313f2f144586951cece97ec31f6d72361df | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-06 | 183 | 133 | 7 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.33e-06 | 183 | 133 | 7 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-06 | 184 | 133 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-06 | 184 | 133 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-06 | 184 | 133 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-06 | 184 | 133 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.43e-06 | 185 | 133 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 1.43e-06 | 185 | 133 | 7 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-06 | 185 | 133 | 7 | 3d73b3e0bceb192257e5cfbe64b7ccb379b6e22d | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.43e-06 | 185 | 133 | 7 | 9d424a8608b339dd6129c58d87626678d4ec4af7 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|bone_marrow / Manually curated celltypes from each tissue | 1.48e-06 | 186 | 133 | 7 | e82d5e7a976b9cfa2b4640c7a7cd1cfea19c4806 | |
| ToppCell | Dividing_Macrophages-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.48e-06 | 186 | 133 | 7 | 0067eb78d4c7e32b9563550d9fcaf13445ee6a48 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-06 | 187 | 133 | 7 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-06 | 187 | 133 | 7 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-06 | 187 | 133 | 7 | a2076599b33ae6750961b573bfebcb9036fa4ee8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-06 | 187 | 133 | 7 | 38ee33295a21db4aae5ba085df033db9693e41c6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-06 | 187 | 133 | 7 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-06 | 187 | 133 | 7 | dbcec24d2c852964736c78e9d81650bff5c455ae | |
| ToppCell | COVID-19-kidney-CD-IC-B|kidney / Disease (COVID-19 only), tissue and cell type | 1.53e-06 | 187 | 133 | 7 | ce05b89860573fe0356102e2998d1ef6d1968034 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-06 | 188 | 133 | 7 | 319fbeca200ab998daf49fcaee0bfdb57bf7ee4b | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-06 | 188 | 133 | 7 | 95d0a796d62ce6d121e2028c378faffc14b35275 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.64e-06 | 189 | 133 | 7 | fd8834d1feb7f63911c5fa51efb1f679a8baddeb | |
| ToppCell | Dividing_Macrophages-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.64e-06 | 189 | 133 | 7 | d4e88a3e50499d683e3db38aee04490146fe30bb | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.64e-06 | 189 | 133 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| Computational | Genes in the cancer module 387. | 3.35e-05 | 49 | 82 | 5 | MODULE_387 | |
| Computational | Genes in the cancer module 329. | 4.08e-05 | 51 | 82 | 5 | MODULE_329 | |
| Computational | Neighborhood of CDC2 | 1.05e-04 | 62 | 82 | 5 | GNF2_CDC2 | |
| Computational | Neighborhood of CCNA2 | 1.63e-04 | 68 | 82 | 5 | GNF2_CCNA2 | |
| Computational | Muscle genes. | 1.72e-04 | 37 | 82 | 4 | MODULE_512 | |
| Computational | Genes in the cancer module 201. | 5.55e-04 | 50 | 82 | 4 | MODULE_201 | |
| Computational | Genes in the cancer module 222. | 5.94e-04 | 22 | 82 | 3 | MODULE_222 | |
| Computational | Genes in the cancer module 168. | 5.94e-04 | 22 | 82 | 3 | MODULE_168 | |
| Disease | Malignant neoplasm of breast | SYNE1 ROR1 LAMA2 ELP3 HOOK3 PAEP WBP4 MKI67 FAM217B MTR ALDOA CDH1 ENO1 GGA1 DOP1A | 7.36e-05 | 1074 | 129 | 15 | C0006142 |
| Disease | vital capacity | MAP2 CWC27 SYNE1 LAMA2 APOB STK31 GFPT1 STX1B STT3A OLIG3 SKAP1 CAPRIN2 CTNNA3 SYCP1 CRIPT | 3.38e-04 | 1236 | 129 | 15 | EFO_0004312 |
| Disease | Liver carcinoma | 4.03e-04 | 507 | 129 | 9 | C2239176 | |
| Disease | Mammary Carcinoma, Human | 5.18e-04 | 525 | 129 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 5.18e-04 | 525 | 129 | 9 | C1257931 | |
| Disease | atopic eczema, psoriasis | 5.24e-04 | 36 | 129 | 3 | EFO_0000274, EFO_0000676 | |
| Disease | Mammary Neoplasms | 5.33e-04 | 527 | 129 | 9 | C1458155 | |
| Disease | Breast Carcinoma | 6.17e-04 | 538 | 129 | 9 | C0678222 | |
| Disease | spontaneous preterm birth, parental genotype effect measurement | 1.02e-03 | 11 | 129 | 2 | EFO_0005939, EFO_0006917 | |
| Disease | Enzymopathy | 1.02e-03 | 11 | 129 | 2 | C0520572 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.22e-03 | 12 | 129 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Male sterility | 1.22e-03 | 48 | 129 | 3 | C0917731 | |
| Disease | Male infertility | 1.22e-03 | 48 | 129 | 3 | C0021364 | |
| Disease | Subfertility, Male | 1.22e-03 | 48 | 129 | 3 | C0848676 | |
| Disease | total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement | 1.30e-03 | 49 | 129 | 3 | EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612 | |
| Disease | pneumonia, COVID-19 | 1.55e-03 | 113 | 129 | 4 | EFO_0003106, MONDO_0100096 | |
| Disease | Childhood Ataxia with Central Nervous System Hypomyelinization | 1.67e-03 | 14 | 129 | 2 | C1858991 | |
| Disease | urinary bladder cancer (biomarker_via_orthology) | 1.67e-03 | 14 | 129 | 2 | DOID:11054 (biomarker_via_orthology) | |
| Disease | Carcinoma, Granular Cell | 1.71e-03 | 116 | 129 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.71e-03 | 116 | 129 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.71e-03 | 116 | 129 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.71e-03 | 116 | 129 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.71e-03 | 116 | 129 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 1.71e-03 | 116 | 129 | 4 | C0001418 | |
| Disease | Adenocarcinoma of lung (disorder) | 2.16e-03 | 206 | 129 | 5 | C0152013 | |
| Disease | Squamous cell carcinoma | 2.18e-03 | 124 | 129 | 4 | C0007137 | |
| Disease | myopia (is_implicated_in) | 2.19e-03 | 16 | 129 | 2 | DOID:11830 (is_implicated_in) | |
| Disease | muscular dystrophy (is_implicated_in) | 2.47e-03 | 17 | 129 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | lysophosphatidylcholine 18:1 measurement | 2.47e-03 | 17 | 129 | 2 | EFO_0010360 | |
| Disease | Acute myeloid leukemia | 2.47e-03 | 17 | 129 | 2 | cv:C0023467 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 2.47e-03 | 17 | 129 | 2 | 601626 | |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 2.65e-03 | 216 | 129 | 5 | EFO_0007925, EFO_0007927 | |
| Disease | Bone marrow hypocellularity | 2.77e-03 | 18 | 129 | 2 | C1855710 | |
| Disease | disease free survival | 2.77e-03 | 18 | 129 | 2 | EFO_0000409 | |
| Disease | waist circumference | 2.86e-03 | 429 | 129 | 7 | EFO_0004342 | |
| Disease | apolipoprotein A 1 measurement | CEBPA TMPRSS11E GRB14 RFX6 APOB NRP1 ZC3H4 LPIN2 ABCB11 CDH1 | 4.16e-03 | 848 | 129 | 10 | EFO_0004614 |
| Disease | cytokine measurement | 4.24e-03 | 461 | 129 | 7 | EFO_0004873 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ASKQIAADKQYKGIV | 41 | P12236 | |
| MEKEKIQSNKGSSYK | 2256 | Q9NR09 | |
| KYEALRKQQSKKGTS | 366 | Q6UX04 | |
| QALKDLKKSNTKAYG | 1276 | Q8N7X0 | |
| GKKENLKAAQEEYVK | 316 | P04075 | |
| VQKYGEEQVKSHKKT | 101 | Q0JRZ9 | |
| YNNDKKSRLQDEKKG | 26 | O95342 | |
| EKNISKQKTSKEYLS | 731 | Q5JWR5 | |
| QGIKAKFQEKYQKSL | 281 | P27216 | |
| LKDKYKNIGAKLVQD | 86 | P10809 | |
| KNDTSGEYKKTLLKL | 306 | P08133 | |
| TKAQYLAAKALKKQS | 681 | O75175 | |
| DKKKNYKSSGTVVLA | 271 | O95741 | |
| YKKKKEAQDKANSAS | 496 | Q9Y4C8 | |
| KTKAADQYLSQKKTI | 96 | Q8HWS3 | |
| KNKENVYTPKSAVKN | 421 | Q14680 | |
| VQNKSKSLNYTGEKK | 1216 | Q9NVI1 | |
| GEKTENPKKFKINYT | 91 | P09466 | |
| KSYKGANSKIEKKQS | 81 | O15480 | |
| KAKKNKDKYVGVSSD | 151 | Q14677 | |
| GSTKNKKQLKQPYTE | 521 | Q6NUN7 | |
| SSKNTKLKGYQKRDV | 641 | Q6NUN7 | |
| KTNAKLFSEVKYKEG | 536 | Q86VF7 | |
| DQKEKATLLGNKKDY | 56 | Q9BQS8 | |
| QSAKDKQPYEQKAAK | 136 | P26583 | |
| GANTQVTEKNKKEYI | 1426 | Q76N89 | |
| DPTLIGDDKNKKKYS | 696 | Q5H9U9 | |
| TKNKFKVLYEKEQKG | 1156 | Q10570 | |
| DSINKAKYLTKKTQA | 256 | P49005 | |
| KYKADTLKVAQTGQD | 251 | Q14232 | |
| GNYSTTQKTFKVKDK | 161 | P05160 | |
| VTKYQKRKNKLEGDS | 1956 | Q92614 | |
| APGKQNEEKTYKKTA | 11 | O14986 | |
| SEKKLKTNGVKQNTY | 366 | Q9NTX9 | |
| KLEKLDTDLKNYKGN | 141 | Q13098 | |
| QAGKYSKTVASEKLK | 606 | O00566 | |
| KYLGSRTSEKVKNKI | 101 | Q9UJY5 | |
| KKNYNKLADSVAKTN | 2066 | P24043 | |
| KAQDSKAYSKITEGK | 136 | P46013 | |
| DKVSKLEGQVESYKK | 311 | Q86VS8 | |
| KYTSLQEEAQGKTKK | 531 | Q9Y496 | |
| KQKLVQTQGTKEKVY | 541 | P42694 | |
| GKKESEEDQSKSYKQ | 61 | Q96MC2 | |
| ESSKYKIKKQLSEQD | 66 | Q7RTU3 | |
| KAFVQKNLVYGTTKK | 441 | Q9H0J9 | |
| GVKLKKDKLNTQSTY | 906 | O14786 | |
| FYTIDTGQKKTLDKK | 71 | Q8N573 | |
| NKSDLQKTYQKLGKE | 166 | Q9UI47 | |
| NLKNVIKEKYGKDAT | 191 | P06733 | |
| KQSFDLSVKAQYKKN | 3166 | P04114 | |
| ENKLKKYNKPSETVI | 206 | Q13042 | |
| TKKLSDYVGKNEKTK | 201 | P57076 | |
| NDQKSSGIEYTKVVK | 716 | Q9Y2F5 | |
| AVNNITAKGITDYKK | 321 | P54289 | |
| AGKAKKSVDKNSNEY | 271 | P49715 | |
| CGKKVLDTKNYKQTS | 86 | Q9P021 | |
| VENESYVNLKKKISK | 491 | Q6P158 | |
| LKYKSKVSLKGNRES | 436 | Q9NYF8 | |
| RKLQKEASGSKYKAI | 6 | Q5TH69 | |
| LQKVKKSVKAIYNSG | 71 | Q9ULH1 | |
| TPKSKAGYVQEEQKK | 476 | Q6IMN6 | |
| IDLNKVKTKTAAKYG | 36 | Q9H9T3 | |
| VATEYQENKAPGKKK | 1196 | O95239 | |
| KANSRKKQVIKVYSE | 101 | Q14449 | |
| SLSEKNFKQVLKKYD | 36 | O14958 | |
| EKKEAKQKYTDHLQS | 751 | Q9NV70 | |
| QDLEKSKKYSGKNLK | 501 | Q96QF7 | |
| KVKYSIKGQDTIFKN | 406 | Q8NDH2 | |
| IYKGNSEKNVKIEKN | 2561 | Q8NDH2 | |
| KSTYEQVDLIGKKTQ | 391 | Q9NR30 | |
| VQIKSNKDKEGKVFY | 176 | P12830 | |
| KEYLKIKQSFQKSNS | 496 | Q86T96 | |
| KKQQYQTSCVALKKG | 271 | Q8NEY4 | |
| QSSGKDKNYTSIKEK | 376 | Q9NRR4 | |
| DAKLNLENKDYKKTT | 591 | P07814 | |
| QKKDSGGKVYKQATI | 16 | Q96MN5 | |
| GKVYKAQNKETSVLA | 46 | Q9H2G2 | |
| NYKQKDLDNFTSKGK | 2136 | Q8NF91 | |
| EKKAQLSKYKSLQQT | 3851 | Q8NF91 | |
| IYSVKNDKNKSDLKV | 201 | O75446 | |
| ITNYKDLKKFLESKG | 126 | Q06210 | |
| NKKVSYLSKQEKSLF | 261 | Q6UWF7 | |
| AKKQYEKAVSQGKTA | 111 | Q06033 | |
| KTKNNYPKIDLDGKE | 526 | Q5VWT5 | |
| DQKAYKEGKLQKALE | 81 | O15355 | |
| SNLKSKYFAVGKISK | 1221 | Q99707 | |
| ATGEKEENVKKNRYK | 51 | Q05209 | |
| RYLDVKKTNKKESIN | 476 | Q6AI14 | |
| KSKKQQDSTYPIKNE | 441 | P46977 | |
| VYSKKGLEHKKELQQ | 381 | Q7Z7L1 | |
| SYTKDLDFKVNKSKQ | 936 | Q562F6 | |
| EYAKGKIKSSQDGKV | 46 | P11055 | |
| QKKNTESVKGLRKYE | 1831 | P11055 | |
| LLVQYATGKKSSKNK | 246 | Q9NVU7 | |
| KSKENVLYKKQEGTP | 421 | P62191 | |
| SIGVKHKKQGYSNKE | 431 | Q9Y2K9 | |
| NYSKTHGKTEEEKEK | 671 | O60284 | |
| EYLAAKGKLKSQNTK | 21 | Q8IYA6 | |
| AKTKGNKVNVGVKYA | 131 | P51911 | |
| VFGNKSQKPYKIDSK | 901 | Q01973 | |
| SNLIKAKSYIEEKKN | 221 | Q9BXT8 | |
| TVQAKYKDSIEFKKQ | 601 | Q9BXU1 | |
| KIKKINKTETDSYLN | 161 | Q9UL52 | |
| KATNNKGKEKIYSAE | 291 | Q16881 | |
| KNSYEQKAKESLQKV | 276 | Q9Y228 | |
| KQKIKDGSATNKEYI | 36 | Q96T68 | |
| LKKQFYKASQLVSEK | 6 | Q99961 | |
| KYLKRGTEQEAAKNK | 656 | Q9Y2W1 | |
| KNKQKYQEETSFAEK | 646 | Q70EL2 | |
| QRDSVLKKSYKLKGT | 386 | Q8NB66 | |
| LYKENKAKENPLKTS | 56 | Q4G0A6 | |
| QGKTEKHESQKDYVK | 216 | Q14247 | |
| DEFKTKYKINVKENS | 246 | O95757 | |
| KKKGTAESKQLNVYE | 626 | Q15431 | |
| VNNTKEKFGLAVKYK | 261 | Q8N4C7 | |
| AVSDTKKAVKYQSKA | 246 | P61266 | |
| KKEDYVLTKFNVQKT | 311 | Q9P2N2 | |
| NEEKSKTLKKSNPYG | 281 | O75554 | |
| TYGNKAKKQKTTLLF | 286 | Q04864 | |
| SKSKNNEQEVKYKGD | 871 | Q86X10 | |
| QQSDKKGKVICKYFV | 386 | Q9UPT8 | |
| KNVKSKIGSTDNIKY | 1671 | P11137 | |
| KQYGKLKKFTTVNPE | 1441 | Q86YA3 | |
| DIDKIKSQNPGKYKV | 116 | Q2M2D7 | |
| KLIKSYQKSQKDISE | 266 | Q9BXG8 | |
| SIHSKQIEGNKKYLK | 541 | Q5SVZ6 | |
| SNDYGENEKQKKKEK | 166 | Q9Y2D9 | |
| QEKGDKGVSKIKIYN | 361 | Q6NT04 | |
| GLGEEQKQVYKKKTE | 301 | O94900 | |
| DNVIKQGYLEKKSKD | 106 | Q86WV1 | |
| YKLQGKEAVKEKNVC | 551 | Q562E7 | |
| KSTEYKAKDDTQVKG | 251 | Q9NYU2 | |
| NSKKNLEYIEKLEGK | 116 | Q2M3W8 | |
| KYKQDSKKEEQAASA | 161 | Q92539 | |
| QYFKNKVKCGLDKET | 161 | Q5VVJ2 | |
| KQYKKDLENEIKGKG | 521 | O76041 | |
| NKKAGVAASKVKYKE | 336 | P20929 | |
| VKKAGDALNEKKYRQ | 1216 | P20929 | |
| GKIQSEREYKKEFQK | 3796 | P20929 | |
| QKTKGKYHTVKDALD | 5271 | P20929 |